section name header

Pronunciation

DAS-i-GLOO-ka-gon

Classifications

Therapeutic Classification: hormones

Pharmacologic Classification: pancreatics

Indications

REMS


Action

  • Stimulates glucagon receptors in liver, which stimulates the breakdown of glycogen and release of glucose from the liver.
Therapeutic effects:
  • Increase in blood glucose.

Pharmacokinetics

Absorption: Unknown.

Distribution: Widely distributed to tissues.

Metabolism/Excretion: Excreted through proteolytic degradation pathways in blood, liver, and kidney.

Half-Life: 30 min.

Time/Action Profile

(increase in blood glucose concentrations)

ROUTEONSETPEAKDURATION
SUBQ10 min60 minUnknown





Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Interactions

Drug-drug:

Route/Dosage

Availability

Assessment

Lab Test Considerations:

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Zegalogue